Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Anterior Resection Syndrome: Retrograde Enema Program vs Medical Management
NCT06424522Recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Feb 2027
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in low anterior resection syndrome (LARS) (2 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Fecal incontinence at 1 year and Effectiveness assessed using LARS validated scoring tool at 1 year. Planned start Feb 2027; status: recruiting.
02
Conditions
low anterior resection syndrome (LARS)
Beyond the preview
Go deeper on NCT06424522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06424522.